[The structure of the nucleolus during the inhibition of RNA-and protein synthesis (author's transl)].
In cells treated with antimetabolites to inhibit RNA- and protein synthesis, electron microscopic studies reveal structural alterations of the nucleolus. The morphological appearance of the nucleolus differs depending of the inhibitor used. If transcription is prevented, segregation of nucleolar components is observed. Inhibition of processing of newly synthesized RNA results in a degranulation and an increase in the amount of nucleolar fibrils. A disturbance of the release of nucleolar ribonucleoproteins into the cytoplasm leads to an enlargement and a hypergranulation of the nucleolus. On the other hand interruption of translation of mRNAs has no immediate effect on the appearance of the nucleolar structure. Only after longer treatment of the cells with the translation inhibitor the nucleolus shrinks and becomes degranulated. The use of inhibitors with clearly defined mechanisms of action in a morphological study should make it possible to interpret similar nucleolar alterations seen in cancer cells and virus-infected cells on a molecular biological basis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology*; D002466:Cell Nucleolus / Q000648:ultrastructure*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D008099:Liver / Q000166:cytology; D014176:Protein Biosynthesis / Q000187:drug effects*; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D013853:Thioacetamide / Q000494:pharmacology; D014127:Toyocamycin / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*; D014170:Transformation, Genetic / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D013853:Thioacetamide; D003609:Dactinomycin; D012313:RNA; D003513:Cycloheximide; D014127:Toyocamycin
Die Struktur des funktionsgestörten Nukleolus.